Related Experiment Video
Updated: Aug 28, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
A Novel Antimicrobial Peptide Displaying Broad-Spectrum Activity Against Pan-Resistant Pathogens and Low Propensity
Betul Zehra Temur1,2, Esma Bolat2, Meltem Ayas3,4
1Department of Biomedical Engineering, Graduate School of Natural and Applied Sciences, Acibadem University, Istanbul 34752, Türkiye.
Objectives:
The escalation of multidrug-resistant (MDR) clinically relevant bacterial isolates, including Escherichia coli and key ESKAPE pathogens, represents a critical global healthcare threat. While antimicrobial peptides (AMPs) offer promising alternatives, metabolic instability often limits their clinical use. This study investigated the therapeutic potential, antimicrobial efficacy, and resistance dynamics of peptide D-TN6 against highly resistant bacterial strains.
Methods:
D-TN6 efficacy was evaluated against 164 clinical isolates, including pan-drug-resistant, carbapenem-resistant, and polymyxin-resistant phenotypes. A 20-passage serial induction assay compared resistance development kinetics of D-TN6 against gentamicin over an extended period.
Results:
D-TN6 demonstrated potent efficacy against MRSA (minimum inhibitory concentration (MIC)90: 1 µg/mL) and remained effective against polymyxin B-resistant Klebsiella pneumoniae (MIC90: 8 µg/mL) and pan-drug-resistant Acinetobacter baumannii (MIC90: 8 µg/mL). In resistance assays, while the gentamicin MIC increased 256-fold by the 17th passage, the D-TN6 MIC remained constant at 1 µg/mL throughout the 20-passage study.
Conclusions:
These findings underscore D-TN6 as a robust therapeutic candidate. Its efficacy against MDR strains and its feature of low propensity for resistance development-likely due to membrane disruption-position D-TN6 as a promising solution for life-threatening infections where conventional last-resort agents fail.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing

